Bayer AG and Johnson & Johnson agreed to pay $775 million to settle more than 25,000 U.S. lawsuits tied to their blood thinner Xarelto, according to Reuters. The settlement resolves all outstanding ...
For people taking popular blood thinners after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospital visits, a Michigan Medicine-led study suggests. The ...
Bayer expects its pharmaceutical business to return to growth in 2027, unit President Stefan Oelrich said Monday. The German conglomerate is planning to launch new therapies — one that treats a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback